The need for an individual approach to lung cancer treatment

PLoS Med. 2006 Apr;3(4):e206. doi: 10.1371/journal.pmed.0030206. Epub 2006 Apr 25.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Antineoplastic Agents / therapeutic use
  • DNA Mutational Analysis
  • Enzyme Inhibitors / pharmacology*
  • Enzyme Inhibitors / therapeutic use
  • ErbB Receptors / genetics
  • ErbB Receptors / physiology
  • Humans
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / genetics*
  • Patient Selection
  • Protein-Tyrosine Kinases / antagonists & inhibitors

Substances

  • Antineoplastic Agents
  • Enzyme Inhibitors
  • ErbB Receptors
  • Protein-Tyrosine Kinases